Stock Movers: Pharma Stocks Sink, Gold Stalls, and Tech Rallies on Easing Trade Tensions

Market Reaction to US-China Agreement

• 🎯 The market is divided into two main reactions following the 90-day US-China agreement: positive responses to de-escalation and negative responses to potential US pharmaceutical regulations.
• 📈 A broad "risk-on" narrative is driving significant gains in technology stocks, while other sectors experience declines.

Pharmaceutical Sector Decline

• 📉 Pharmaceutical stocks, including AbbVie (ABBV), Eli Lilly (LLY), and Gilead Sciences, are experiencing significant drops.
• ⚠️ This downturn is attributed to President Trump's potential executive orders aimed at reducing US prescription drug costs by aligning them with prices in other countries.

Gold and Mining Sector Impact

• ⚠️ Newmont (NEM), a gold mining company, is also down approximately 6%, mirroring the broader macro trend.
• 📊 The decline in gold prices is linked to investors shifting attention back to US equities amidst easing trade tensions with China.

Technology Sector Rally

• 🚀 Companies with significant exposure to China and Taiwan, particularly in the semiconductor industry, are seeing substantial gains.
• 💡 Texas Instruments (TXN) and Broadcom (AVGO) are up around 6%, while Qualcomm (QCOM) has risen 7%.
• 📱 Apple (AAPL) is rallying significantly, up 6.7%, due to its extensive supply chain in China and potential reporting on raising iPhone prices.
• 📈 Other major tech stocks like Dell (DELL), Tesla (TSLA), and Amazon (AMZN) are also experiencing strong upward movement, with Amazon showing the largest pre-market gain at 8.2%.